Article 1 to 1 out of 1 concerning Nabriva Therapeutics AG
GLSV co-finances Sandoz spin-off Nabriva GmbH(02/02/2006) Global Life Science Ventures (GLSV) announced the launch of Nabriva GmbH, a specialist antibiotic research and development company that has existed until now within Sandoz GmbH as the Vienna-based Antibiotic Research Institute (ABRI). GLSV is ...
Top
